U.S. Tech Hardware Stock News

On 12 March 2026, Fareway Stores announced it had adopted Instacart’s Storefront Pro platform and joined the Instacart Marketplace with no markups on pickup orders, bringing a unified online and app-based grocery shopping experience to its more than 140 Midwestern locations. The partnership showcases Instacart’s enterprise capabilities, such as AI-powered search, integrated fulfillment, and Carrot Ads retail media, which can deepen retailer relationships and broaden higher-margin technology...

If you are wondering whether Cloudflare's share price still makes sense after its strong run, this article will help you unpack what that current price could imply about the company. Cloudflare's stock last closed at US$212.45, with returns of 8.8% over the past week, 12.2% over the past month, 8.4% year to date and 82.9% over the past year. The 3 year and 5 year returns stand at 289.6% and 196.3% respectively. Recent coverage around Cloudflare has continued to focus on its role in content...

Novo Nordisk and Hims & Hers have resolved their legal dispute and entered into a new distribution partnership. Hims & Hers will move patients from compounded GLP-1 products to Novo Nordisk's branded obesity medicines, including Ozempic and Wegovy. As part of the agreement, Hims & Hers will stop promoting compounded GLP-1 alternatives, and Novo Nordisk will withdraw its lawsuit. The deal broadens digital access to Novo Nordisk's FDA approved therapies and tightens control over prescription...

Earlier this month, Hagerty’s Broad Arrow Auctions division set a company and event record at The Amelia Concours, generating over US$111,000,000 in total sales during the 31st running of the classic car celebration. The record auction performance underscores Hagerty’s expanding role in the collector car ecosystem, reinforcing how event-driven services can complement its core insurance and enthusiast offerings. We’ll now examine how Broad Arrow’s record auction sales might influence...

If you are trying to work out whether Ocular Therapeutix at around US$8.76 is a bargain or just fairly priced, starting with a clear view of its valuation can help frame your next move. The stock has seen mixed returns, with a 14.7% decline over the last 7 days and a 4.4% decline over the last 30 days, while the 1 year return sits at 13.5% and the 3 year return at 76.6%, compared with a 57.6% decline over 5 years. Recent market attention on Ocular Therapeutix has focused on its progress as...

Brown-Forman (BF.B) is back in focus after Bernstein cut its rating, citing ongoing margin pressure from higher barrelled whisky costs and softer demand, even though recent quarterly results came in ahead of expectations. See our latest analysis for Brown-Forman. At a share price of $23.49, Brown-Forman has seen momentum fade, with a 30 day share price return of 22.42% and a 90 day share price return of 23.63%. The 5 year total shareholder return of 62.11% highlights how prolonged the...

How BioMarin Pharmaceutical’s Recent Moves Set Up a Closer Look at Value Before we get into the numbers, if you are wondering whether BioMarin Pharmaceutical’s current share price fairly reflects its long term potential, it helps to first step back and see what the market has been doing with the stock lately. BioMarin’s share price closed at US$58.51 most recently, with returns of 4.3% decline over the past week, 3.0% decline over the past month, a 1.6% decline year to date, and a 15.7%...

Investor sentiment toward Concentrix (CNXC) came under pressure as escalating geopolitical tensions triggered a broad risk off move, pulling down business process outsourcing and consulting stocks alongside the wider sector. See our latest analysis for Concentrix. At a recent share price of US$31.67, Concentrix has seen a 7 day share price return of about a 10% decline and a year to date share price return of roughly a 23% decline. The 1 year total shareholder return of around a 28% decline...

Adobe reported first-quarter 2026 results with revenue of US$6.40 billion and net income of US$1.89 billion, while also issuing second-quarter guidance and confirming a leadership transition as long‑time CEO Shantanu Narayen plans to step down once a successor is appointed. Beyond the headline earnings beat, the combination of Narayen’s planned departure, an extensive share repurchase program, and growing AI‑related partnerships such as the expanded Major League Baseball deal is reshaping...

Capital Clean Energy Carriers Corp. recently reported fourth-quarter 2025 sales of US$98.35 million and full-year sales of US$392.71 million, alongside appointing veteran energy executive Martin Houston as Chairman and moving Keith Forman to Vice-Chairman. The combination of higher annual sales and earnings per share from continuing operations with Houston’s extensive global energy leadership experience could meaningfully influence how investors assess the company’s long-term...

Edgewise Therapeutics recently presented long-term data from its MESA open-label extension study of sevasemten in Becker muscular dystrophy at the 2026 MDA Clinical and Scientific Conference, showing multi-year stabilization of patient function and a favorable safety profile in a disease with no approved therapies. An unusually high 99% of eligible participants from earlier sevasemten trials chose to continue into the MESA extension, underscoring sustained engagement with the investigational...

Executive change at HF Sinclair HF Sinclair (DINO) has appointed Mr. Vivek Garg as acting Chief Financial Officer, a move that puts fresh attention on leadership stability and financial oversight for investors tracking the stock. See our latest analysis for HF Sinclair. HF Sinclair’s 1-day share price return of a 2.72% decline and 1-month share price return of a 5.16% decline sit against a stronger 90-day gain of 12.84% and 1-year total shareholder return of 79.84%. This contrast highlights...

Merchants Bancorp (MBIN) is back in focus after its latest earnings report showed revenues, EPS, and net interest income all ahead of analyst estimates, highlighting its low-risk, government-backed lending model. See our latest analysis for Merchants Bancorp. The latest earnings beat comes after a mixed price pattern, with a 10.52% 1 month share price decline, a 14.99% 3 month share price return, and a 25.56% year to date share price return, alongside a 63.14% 3 year total shareholder return...

Market shock around LNG flows puts Golar LNG in focus A conflict driven closure of shipping routes in the Strait of Hormuz has disrupted roughly 19% of global LNG exports, injecting fresh volatility into gas markets and pulling Golar LNG (GLNG) into sharper investor focus. See our latest analysis for Golar LNG. The LNG route disruption comes after a choppy few weeks for Golar LNG, with a 1-day share price return of a 4.13% decline and a 7-day share price return of an 8.79% decline. However, a...

Pegasystems recently expanded its Pega Blueprint offering with an end-to-end “vibe coding” experience, enabling conversational AI-driven app design at enterprise scale while maintaining governance, security, and maintainability. A fresh endorsement from Forrester as a Leader in customer service solutions, alongside these AI-powered workflow tools, highlights Pega’s push to make complex enterprise automation more accessible to both business and technical users. We’ll now examine how Pega’s...

In recent days, Crown Holdings reported strong fiscal 2025 results, with revenue and earnings growth supported by European shipments and favorable currency effects, while Jefferies reaffirmed its positive view citing the company’s advanced Bowling Green manufacturing plant. Beyond headline growth, the emphasis on high-tech, efficient production at Bowling Green underlines how manufacturing quality and innovation are becoming central to Crown’s competitive position. Now we’ll explore how this...

In recent days, ServiceNow has expanded its AI footprint with new public sector offerings like EmployeeWorks and Autonomous Workforce, while partners including Cohesity, Aiva Health, Autonomize AI, NTT DOCOMO and StarHub announced integrations that embed ServiceNow’s AI platform into data security, healthcare, telecom roaming and payer operations workflows. Together with fresh recognition in a Forrester public sector cloud report and new ESOP-related shelf registrations, these moves...

In March 2026, Northern Oil and Gas, Inc. completed a follow-on equity offering of approximately US$200.00 million, issuing 7,207,208 common shares at US$27.75 each and granting underwriters a 30-day option to purchase up to an additional 1,081,081 shares. This sizable capital raise, which increases the company’s share count, highlights management’s willingness to tap equity markets to support its growth and acquisition agenda. We’ll now examine how this sizeable equity issuance, and the...

If you are wondering whether Veralto, at around US$90.20, is offering fair value right now or if the market is mispricing it, this article walks you through what the numbers actually say. The stock has recently been under pressure, with a 7 day return of a 4.4% decline, a 30 day return of a 5.1% decline and a year to date return of an 8.4% decline, adding to a 1 year return of a 7.5% decline. Recent coverage around Veralto has focused on how the newly listed business fits into the broader...

If you are wondering whether Terex shares are still offering value at current levels, you are not alone. This article will walk through what the market price might be implying about the business. The stock last closed at US$59.41, with returns of 8.0% year to date and 49.4% over the past year. However, a 4.3% decline over the last week and a 14.0% decline over the last month shows sentiment has recently cooled. These short term moves sit against a longer backdrop where Terex has also...

Exelixis recently reported quarterly adjusted earnings per share that exceeded expectations, helped by higher Cabometyx volumes and lower operating expenses, while the FDA accepted its New Drug Application for zanzalintinib in metastatic colorectal cancer with a target action date in December 2026. Alongside these results, the company reiterated its 2026 guidance and benefited from multiple upward analyst earnings estimate revisions, underscoring how regulatory milestones and disciplined...

Why Hims & Hers Health (HIMS) is on investors’ radar Hims & Hers Health (HIMS) has drawn fresh attention after a sharp 57% move over the past week. This has prompted investors to reassess how its recent share performance lines up with reported revenue and net income figures. See our latest analysis for Hims & Hers Health. That sharp 57.4% 7 day share price return and 48.4% 30 day share price return come after a weaker patch, with the 90 day share price return at a 33.4% decline and year to...

Italian prosecutors have requested a criminal trial for Amazon.com's European unit and four managers over alleged €1.2b VAT evasion, despite an earlier settlement payment. Separately, an EU court in Luxembourg has overturned a €746m GDPR privacy fine against Amazon, citing issues with the regulator's analysis. These contrasting outcomes raise fresh questions about Amazon's regulatory exposure and operating model across key European markets. Amazon.com, ticker NasdaqGS:AMZN, last closed at...

CRH plans to delist its ordinary and preference shares from the London Stock Exchange, subject to shareholder approval. If approved, the company will maintain a sole primary listing on the New York Stock Exchange under the ticker NYSE:CRH. The move is intended to consolidate trading in one market and could affect how different groups of investors access and trade the shares. NYSE:CRH currently trades at $99.82, with the share price showing a 4.1% gain over the past year and a 132.7% return...